Paid Clinical Trials High Point
Discover 1,134 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)
Sponsor:
Rare Thyroid Therapeutics International AB
Location:
Code:
NCT05579327
Conditions
Monocarboxylate Transporter 8 Deficiency
Allan-Herndon-Dudley Syndrome
Eligibility Criteria
Sex: Male
Age: 4+
Healthy Volunteers: Not accepted
Interventions
Tiratricol
Placebo
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers
Sponsor:
Intercytex
Location:
Code:
NCT00232973
Conditions
Leg Ulcer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ICXP007
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
Sponsor:
University of North Carolina, Chapel Hill
Location:
Code:
NCT06405373
Conditions
Diabetes type1
Diabetes Mellitus, Type 1
Diabetes, Autoimmune
Diabetes Mellitus
Distress, Emotional
Eligibility Criteria
Sex: All
Age: 30+
Healthy Volunteers: Not accepted
Interventions
ReCharge
TakeCharge
A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT05831176
Conditions
Eosinophilic Gastritis
Eosinophilic Duodenitis
Eosinophilic Gastrointestinal Disease
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Dupilumab Dose 1
Dupilumab Dose 2
Matching Placebo
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04181060
Conditions
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
Stage IIIB Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bevacizumab
Biospecimen Collection
Computed Tomography
Echocardiography
Magnetic Resonance Imaging
A Phase 2 Clinical Study in Children With HeFH Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing
Sponsor:
Esperion Therapeutics, Inc.
Location:
Code:
NCT05694260
Conditions
Hypercholesterolemia
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Bempedoic acid
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Sponsor:
TScan Therapeutics, Inc.
Location:
Code:
NCT05812027
Conditions
Head and Neck Cancer
Cervical Cancer
Non Small Cell Lung Cancer
Melanoma
Ovarian Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tumor and HLA Profiling
NBTXR3 With or Without Cetuximab in LA-HNSCC
Sponsor:
Nanobiotix
Location:
Code:
NCT04892173
Conditions
Locally Advanced Head and Neck Squamous Cell Carcinoma
Aged
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
NBTXR3
Cetuximab
Radiation Therapy
Dyad Plus Effectiveness
Sponsor:
Wake Forest University Health Sciences
Location:
Code:
NCT04036331
Conditions
Weight Loss
Pediatric Obesity
Overweight Adolescents
Parent-Child Relations
Family and Household
Eligibility Criteria
Sex: All
Age: 13 - 65
Healthy Volunteers: Not accepted
Interventions
Brenner FIT Standard
By Design Essentials
Dyad Plus